Abstract

Reactions between (meso-tetraphenylporphyrinato)iron(III) perchlorate [Fe(tpp)]ClO 4 and various imidazoles have been examined in CD 2Cl 2 solutions. 1H NMR analysis revealed the formation of three kinds of complex; μ-oxo dimer, mono-imidazole adduct, and bis-imidazole adduct. The product ratios changed to a great extent depending on the amount and nature of imidazoles. In general, addition of less than 1.0 equiv of imidazole relative to [Fe(tpp)]ClO 4 led to the formation of both μ-oxo dimer and mono-imidazole adduct. However, by the addition of excess amount of imidazole, either the μ-oxo dimer or bis-imidazole adduct was formed exclusively depending on the bulkiness of the imidazole used. In the case of bulky imidazole such as 2-methylbenzimidazole or 2-isopropyl-1-methylimidazole, the μ-oxo dimer was formed quantitatively. In the case of less bulky imidazole such as parent imidazole or 1-methylimidazole, bis-imidazole adduct became the sole product. The results have been explained in terms of the difference in steric interactions between the axial ligands and porphyrin core; the severe steric repulsion prohibits the formation of bis-adduct in the case of bulky imidazoles. As a result, bulky imidazoles prefer to behave as a base; they abstract a proton from coordinated water, and lead to the formation of μ-oxo dimer. Thus, the role of bulky imidazoles in these reactions has some relevance to that of distal histidine in hemoglobin and peroxidase.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.